Found 156 matching trials
Study of CAR-T Cell Therapy in the Treatment of Relapsed/Refractory Hematological Malignancies PHASE1 The primary purpose of this study is to determine the safety and efficacy o...
Show More Location
The Affiliated People's Hospital of Ningbo University
Learn More & Join Trial
the Sequential Therapy of CD19-targeted and CD20-targeted CAR-T Cell Therapy for Diffuse Large B Cell Lymphoma(DLBCL) PHASE1 The main purpose of this study is to explore the sequential therapeutic eff...
Show More Location
Southwest Hospital of Third Millitary Medical University
Learn More & Join Trial
CRISPR (HPK1) Edited CD19-specific CAR-T Cells (XYF19 CAR-T Cells) for CD19+ Leukemia or Lymphoma. PHASE1 This is a first-in-human trial proposed to test CD19-specific CAR-T cells w...
Show More Learn More & Join Trial
A Phase 1/2 Study of CT120 in Patient With Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma PHASE1 This study is a single-armed, open-label,multicenter Phase 1/2 study to eva...
Show More Location
Multiple Locations
Learn More & Join Trial
Relmacabtagene Autoleucel in Hematologic Malignancies N/A To evaluate the efficacy and safety of Relmacabtagene Autoleucel in the tre...
Show More Location
Beijing Cancer Hospital
Learn More & Join Trial
Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia PHASE2 This trial aims to demonstrate the feasibility of this approach to reliably...
Show More Location
AHN Cancer Institute - West Penn Hospital
Learn More & Join Trial
Bispecific Antibody-Based Salvage Therapy Followed by CAR-T ± ASCT in R/R Aggressive B-Cell Lymphoma PHASE2 This study consists of two sequential treatment phases. In the first phase,...
Show More Location
Institute of Hematology & Blood Diseases Hospital
Learn More & Join Trial
A Study Evaluating the Safety and Efficacy of Brexucabtagene Autoleucel (KTE-X19) in Adult Subjects With Relapsed/Refractory B-precursor Acute Lymphoblastic Leukemia (ZUMA-3) PHASE1 The primary objectives of this study are to determine the safety and effica...
Show More Location
UC San Diego-Moores Cancer Center
Learn More & Join Trial
Autologous CAR-T Cell Therapy for Refractory and Relapsing Ulcerative Colitis: A Single-Center Exploratory Study EARLY_PHASE1 A Single-Center, Open-Label, Single-Arm Exploratory Clinical Study on the U...
Show More Location
Foresea Life Insurance Guangzhou General Hospital
Learn More & Join Trial
Exploratory Study of Anti-BCMA-CD19 CAR-T Cell Therapy in Relapsed or Refractory IgG4-Related Disease PHASE2 The goal of this clinical trial is to test the safety and potential benefit...
Show More Location
Department of Rheumatology and Immunology, the First Medical Center, Chinese PLA General Hospital
Learn More & Join Trial